Intermedical Care and Lab Hospital Public (IMH) Fundamentals 2026 — Revenue Analysis | SniperIQ
Intermedical Care and Lab Hospital Public (IMH) is a TH-listed Healthcare company in Medical - Care Facilities with a market capitalization of ฿706M, trading at ฿2.98 on the SET. This SniperIQ fundamentals page covers Intermedical Care and Lab Hospital Public's valuation, profitability (net margin -22.1%), revenue (฿755M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Intermedical Care and Lab Hospital Public's market cap?
Intermedical Care and Lab Hospital Public (IMH) has a market capitalization of approximately ฿706M, trading at ฿2.98 on the SET. Market cap moves with the live share price.
What is Intermedical Care and Lab Hospital Public's P/E ratio?
Intermedical Care and Lab Hospital Public's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Intermedical Care and Lab Hospital Public?
Intermedical Care and Lab Hospital Public runs a net profit margin of -22.1%, a gross margin of 16.4%, and an operating margin of -6.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Intermedical Care and Lab Hospital Public generate?
Intermedical Care and Lab Hospital Public reported revenue of ฿755M for fiscal year 2025, with net income of -฿189M and earnings per share (EPS) of -0.83. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Intermedical Care and Lab Hospital Public pay a dividend?
Intermedical Care and Lab Hospital Public does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Intermedical Care and Lab Hospital Public financially healthy?
Intermedical Care and Lab Hospital Public carries a debt-to-equity ratio of 1.83x and a current ratio of 0.41x, with a market beta of 0.34. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Intermedical Care and Lab Hospital Public a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Intermedical Care and Lab Hospital Public (IMH) the key facts are: market cap ฿706M, revenue ฿755M, 52-week range 2.7-4.48. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Intermedical Care and Lab Hospital Public's full fundamentals live
Get Intermedical Care and Lab Hospital Public's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.